carbidopa 48.75 MG

RxCUI
1599251
RxNorm name
carbidopa 48.75 MG
Term type
SCDC
Status
Active
Updated
2026-11-06 11:37:18

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
022015
Active start
022015
Multiple ingredient
NO
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
48.75 MG / 1 EACHcarbidopa

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
carbidopa2019

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRcarbidopa 48.75 MG1NAMES
RxNorm Namecarbidopa 48.75 MG1NAMES
TTYSCDC1ATTRIBUTES
RxCUI15992511CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
FDASPLN0000175754Aromatic Amino Acid Decarboxylation InhibitorEPChas_epccarbidopa
FDASPLN0000175755DOPA Decarboxylase InhibitorsMOAhas_moacarbidopa
MEDRTD002230CarbidopaCHEMhas_ingredientcarbidopa
MEDRTD004342Drug HypersensitivityDISEASEci_withcarbidopa
MEDRTD015812Glaucoma, Angle-ClosureDISEASEci_withcarbidopa
MEDRTD008545MelanomaDISEASEci_withcarbidopa
MEDRTD010300Parkinson DiseaseDISEASEmay_treatcarbidopa
MEDRTN0000000203Dopamine Receptor InteractionsMOAhas_moacarbidopa
MEDRTN0000000133Enzyme InhibitorsMOAhas_moacarbidopa
MEDRTN0000000184Monoamine Oxidase InhibitorsMOAci_moacarbidopa
MEDRTN0000009183Increased Central Nervous System Dopamine ActivityPEhas_pecarbidopa

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYHYBRID
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSTRENGTH48.75 MG